Dasatinib: a potential tyrosine kinase inhibitor to fight against multiple cancer malignancies
Fauziya, Akash Kumar Gupta, Arif Nadaf, Shadaan Ahmad, Nazeer Hasan, Mohammad Imran, Amirhossein Sahebkar, Gaurav Jain, Prashant Kesharwani, Farhan Jalees Ahmad
Topics & Concepts
DasatinibImatinibTyrosine kinaseTyrosine-kinase inhibitorMedicineHematologyPharmacodynamicsCancerPharmacokineticsPharmacologyOncologyCancer researchInternal medicineReceptorMyeloid leukemiaChronic Myeloid Leukemia TreatmentsQuinazolinone synthesis and applicationsPI3K/AKT/mTOR signaling in cancer